MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 12.11.2025
AlloVir P/B 2011-2026 | ALVR
P/B Jährlich AlloVir
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.432 | 0.0242 | 2.12 | 3.61 | 3.84 | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 3.84 | 0.0242 | 2.01 |
P/B anderer Aktien in der Pharmaeinzelhändler
| Name | P/B | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
1.28 | - | 2.43 % | $ 254 M |  Germany |
 |
Graybug Vision
GRAY
|
0.242 | - | -11.23 % | $ 9.65 M |  USA |
 |
AbCellera Biologics
ABCL
|
0.995 | $ 3.67 | -1.21 % | $ 1.1 B |  Canada |
 |
ADMA Biologics
ADMA
|
7.92 | $ 16.57 | 1.16 % | $ 3.95 B | USA |
 |
I-Mab
IMAB
|
1.12 | - | - | $ 866 M |  China |
 |
Apellis Pharmaceuticals
APLS
|
7.49 | $ 19.98 | -0.87 % | $ 2.52 B | USA |
 |
Aptorum Group Limited
APM
|
0.347 | $ 0.8 | 1.03 % | $ 4.36 M | China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | USA |
 |
Acer Therapeutics
ACER
|
-0.724 | - | 2.71 % | $ 14 M | USA |
 |
Biophytis SA
BPTS
|
15.7 | - | -13.47 % | $ 169 M |  France |
 |
Ampio Pharmaceuticals
AMPE
|
0.198 | - | -11.43 % | $ 502 K | USA |
 |
Athersys
ATHX
|
11.6 | - | 3.77 % | $ 22.4 M | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
7.56 | - | -18.52 % | $ 27.3 M |  Britain |
 |
AVEO Pharmaceuticals
AVEO
|
2.14 | - | - | $ 521 M | USA |
 |
Brainstorm Cell Therapeutics
BCLI
|
-0.815 | - | -2.5 % | $ 5.88 M | USA |
 |
BioDelivery Sciences International
BDSI
|
1.64 | - | -4.8 % | $ 255 M | USA |
 |
Burford Capital Limited
BUR
|
1.26 | $ 8.39 | -1.87 % | $ 1.39 B | Britain |
 |
Axsome Therapeutics
AXSM
|
98.2 | $ 165.17 | 0.68 % | $ 8.22 B | USA |
 |
BridgeBio Pharma
BBIO
|
-6.31 | $ 65.96 | 2.22 % | $ 12.6 B | USA |
 |
Adverum Biotechnologies
ADVM
|
1.08 | - | - | $ 86.2 M | USA |
 |
CymaBay Therapeutics
CBAY
|
11.7 | - | - | $ 3.45 B | USA |
 |
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - |  Russia |
 |
Avid Bioservices
CDMO
|
6.95 | - | - | $ 789 M | USA |
 |
ARCA biopharma
ABIO
|
1.27 | - | 1052.0 % | $ 415 M | USA |
 |
BioLineRx Ltd.
BLRX
|
19.9 | $ 2.84 | 1.07 % | $ 908 M |  Israel |
 |
BioMarin Pharmaceutical
BMRN
|
1.92 | $ 60.93 | 4.1 % | $ 11.7 B | USA |
 |
Checkpoint Therapeutics
CKPT
|
-12.7 | - | - | $ 169 M | USA |
 |
Caladrius Biosciences
CLBS
|
0.122 | - | -16.75 % | $ 25.8 M | USA |
 |
Alpine Immune Sciences
ALPN
|
1.5 | - | - | $ 2.17 B | USA |
 |
Clovis Oncology
CLVS
|
-0.829 | - | -7.23 % | $ 13 M | USA |
 |
Acorda Therapeutics
ACOR
|
0.154 | - | -24.86 % | $ 820 K | USA |
 |
Checkmate Pharmaceuticals
CMPI
|
0.759 | - | - | $ 231 M | USA |
 |
Acasti Pharma
ACST
|
0.612 | - | 4.01 % | $ 150 M | Canada |
 |
CTI BioPharma Corp.
CTIC
|
-31.3 | - | - | $ 1.2 B | USA |
 |
CohBar
CWBR
|
0.346 | - | -15.44 % | $ 2.2 M | USA |
 |
Cyclacel Pharmaceuticals
CYCC
|
-2.57 | - | -5.98 % | $ 34.1 M | USA |
 |
Cyclacel Pharmaceuticals
CYCCP
|
-50.3 | - | -4.36 % | $ 27 M | USA |
 |
Cabaletta Bio
CABA
|
0.0867 | $ 3.38 | 4.0 % | $ 3.95 M | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
3.42 | - | - | $ 2.18 B | USA |
 |
CureVac N.V.
CVAC
|
5.13 | - | - | $ 867 M | Germany |
 |
Capricor Therapeutics
CAPR
|
6.87 | $ 26.52 | 2.63 % | $ 710 M | USA |
 |
Aeterna Zentaris
AEZS
|
0.781 | - | 5.93 % | $ 314 M | Canada |
 |
AgeX Therapeutics
AGE
|
0.00262 | - | -10.17 % | $ 12.2 K | USA |
 |
Codexis
CDXS
|
4.35 | $ 1.08 | 9.69 % | $ 79.3 M | USA |
 |
Certara
CERT
|
1.01 | $ 7.26 | 0.21 % | $ 1.16 B | USA |
 |
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | USA |
 |
Coherus BioSciences
CHRS
|
-1.08 | $ 1.78 | 7.96 % | $ 168 M | USA |
 |
Entasis Therapeutics Holdings
ETTX
|
2.36 | - | - | $ 105 M | USA |
 |
Evofem Biosciences
EVFM
|
-0.0624 | - | 7.55 % | $ 38.1 M | USA |